• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » GE HealthCare wins FDA nod for next-gen Signa MRI tech

GE HealthCare wins FDA nod for next-gen Signa MRI tech

February 19, 2026 By Sean Whooley

GE HealthCare Signa 3T MRI scanner
The Signa 3T MRI scanner. [Image courtesy of GE HealthCare]
GE HealthCare (Nasdaq: GEHC) announced today that it received FDA clearance for a trio of new MRI offerings.

The FDA cleared the Signa Sprint with Freelium, Signa Bolt and Signa One. Signa Sprint is a 1.5T sealed magnet MRI system, while Signa Bolt is an advanced 3T MRI scanner. Signa One offers an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond.

Altogether, the company says its new MRI systems and technology combat some of the most complex challenges facing the radiology landscape.

GE HealthCare submitted these offerings to the FDA for evaluation in December 2025.

“Achieving FDA clearance of our next-generation Signa MRI technology underscores our commitment to expanding access to high-quality imaging and elevating the standard of care for patients everywhere,” said Kelly Londy, President and CEO, MR at GE HealthCare. “As MRI demand continues to rise across clinical areas, providers need solutions that deliver greater efficiency without compromising diagnostic precision. With this new Signa generation, we’re redefining what’s possible – aiming to bring smarter, faster, more sustainable and more consistent imaging to more patients, across more settings, with confidence.”

More about the new Signa MRI technologies from GE HealthCare

Signa Sprint

Signa Sprint with Freelium offers helium-free technology without compromising clinical or operational efficiency. It supports strong image quality and clarity and integrates with deep learning solutions like Air Recon DL and Sonic DL.

GE HealthCare said the system offers a wide coverage of anatomies and clinical applications. It offers the same power infrastructure as current conventional magnets and features a ventless magnet that enables installation virtually anywhere.

The system also introduces two levels of operational autonomy. Scanning autonomy simplifies workflows, while autonomous magnet monitoring provides protection and recovery through intelligent sensors.

Signa Bolt

Signa Bolt to enhance precision diagnosis for clinicians and help clinicians improve patient outcomes. The company said the system includes its 1.5T MRI system, with both featuring AI-powered workflows for end-to-end exam efficiency.

It offers the company’s most advanced high-field, clinical wide bore 3.0T MRI system. The company said it combines ultra-high gradient performance, intelligent digital radiofrequency (RF) architecture and sustainable design to deliver precision imaging, fast workflows and seamless clinical-to-research flexibility.

GE HealthCare says it achieves all this with low energy consumption and operational costs.

Signa One

Signa One powers both of the newly cleared platforms, improving the imaging experience and streamlining MRI operations. It offers an intuitive experience that can help. reduce training time and aims to boost productivity while shortening the learning curve. Its Signa One table enhances patient comfort and simplifies patient transport, the company says.

GE HealthCare said the fully automated Signa One camera features in-room console live feeds, AI-enabled landmark localization and patient positioning. verification. It has real-time visual guidance on a touchscreen display to improve speed and accuracy.

The system also has contactless respiratory and peripheral gating to capture physiological data effortlessly, regardless of patient orientation. High-resolution, in-room consoles empower technologists with simple patient setup control.

GE HealthCare said it integrated its platforms with Nvidia technology as well to enhance the performance and intelligence of MR. It utilized Nvidia’s RTX product line and Signa One to power Signa Bolt and Sprint.

Filed Under: 510(k), Artificial Intelligence (AI), Food & Drug Administration (FDA), Health Technology, Imaging, Machine Learning (ML), Regulatory/Compliance, Software / IT Tagged With: FDA, GE Healthcare

More recent news

  • FDA warns of Philips ultrasound issues after four patient deaths
  • FDA approves Gore bridging stent graft in complex aortic aneurysms
  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy